• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SMITH & NEPHEW, INC. JRNY II BCS XLPE ART ISRT SZ 3-4 LT 9MM; PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SMITH & NEPHEW, INC. JRNY II BCS XLPE ART ISRT SZ 3-4 LT 9MM; PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL Back to Search Results
Catalog Number 74027241
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Medical device site infection (4845)
Date of Event 02/16/2024
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
H10: internal complaint reference: case (b)(4).
 
Event or Problem Description
It was reported that after a tka surgery for left knee was performed on (b)(6) 2024, the patient experienced an infection.This adverse event was resolved by revision surgery on (b)(6) 2024, during which one (1) jrny ii bcs xlpe art isrt sz 3-4 lt 9mm was exchanged, and a new journey ii bcs insert was implanted.The femoral component, tibial baseplate, and patella component remained.The current health status of the patient is unknown.
 
Additional Manufacturer Narrative
The explanted insert was not returned for evaluation and, given the nature of the alleged incident, the femoral component, tibial baseplate and patella component could not be returned; therefore, a device analysis could not be performed.The clinical/medical investigation concluded that, based on the limited information provided, the patient was revised due to the reported infection, however, the definitive root cause of the reported infection cannot be determined.Post-operative infections are a known occurrence after surgery.Therefore, the reported infection three-week post-left total knee arthroplasty was likely related to the procedure and not a malperformance of the smith and nephew device.Although, a hematogenous spread cannot be ruled out.The impact to the patient beyond the reported infection and subsequent revision cannot be determined since the status of the patient is unknown.A review of the manufacturing records could not be performed for the insert, since the device history record for this production order was not available.This issue was escalated through our quality process.For the rest of the devices, the review of the production orders did not reveal a manufacturing abnormality that could have caused or contributed to the reported incident.A review of complaint history revealed a similar event for the tibial baseplate and similar events for the femoral and patella components over the previous 12 months, but no similar events for the batches based on the historical data.For the insert, a similar event was revealed for the listed batch.This failure mode will be monitored for future complaints for any necessary corrective actions.A review of the instructions for use documents for knee systems revealed that acute post-surgical wound infection has been identified in possible adverse effects.Active, local infection or previous intra-articular infections are identified in contraindications for total knee replacement.A review of the risk management files revealed this failure mode was previously identified.The anticipated risk level is still adequate.A historical review concluded that there are no prior actions related to this products and event.A review of the sterilization records revealed the batches were sterilized within normal parameters.At this time, we have no evidence to conclude that the product failed to meet any specifications at the time of manufacture.Factors that could contribute to the reported event include loss of sterility during procedure, post-operative healing issue, injury, patient condition and/or medical history.Based on this investigation, the need for corrective action is not indicated.Should the devices or additional information be received, the complaint will be reopened.No further investigation is warranted for this complaint; however, we will continue to monitor for future complaints and investigate as necessary.We consider this investigation closed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
JRNY II BCS XLPE ART ISRT SZ 3-4 LT 9MM
Common Device Name
PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL
Manufacturer (Section D)
SMITH & NEPHEW, INC.
1450 brooks rd.
memphis TN 38116
Manufacturer (Section G)
SMITH & NEPHEW, INC.
1450 brooks rd.
memphis TN 38116
Manufacturer Contact
holly topping
7000 west william cannon drive
austin, TX 78735
5123913905
MDR Report Key18941216
Report Number1020279-2024-00576
Device Sequence Number11505594
Product Code JWH
UDI-Device Identifier00885556177617
UDI-Public00885556177617
Combination Product (Y/N)N
Initial Reporter CountryJA
PMA/510(K) Number
K111711
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2024
Device Explanted Year2024
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Other,Foreign,Company Representative
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 05/20/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Catalogue Number74027241
Device Lot Number23CM09649
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 02/29/2024
Supplement Date Received by Manufacturer05/14/2024
Initial Report FDA Received Date03/20/2024
Supplement Report FDA Received Date05/20/2024
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured03/17/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
71932636 / LOT# 23KM13298; 74022126 / LOT# 23AM03021; 74022224 / LOT# 23JM16595
Outcome Attributed to Adverse Event Required Intervention;
Patient SexUnknown
-
-